Effect of sodium-glucose cotransporter 2 inhibitor on vascular endothelial function and diastolic function in patients with heart failure with preserved ejection fraction (HFpEF).

Back

EACVI Premium Access

Effect of sodium-glucose cotransporter 2 inhibitor on vascular endothelial function and diastolic function in patients with heart failure with preserved ejection fraction (HFpEF).

Session: New insights in diastology

Topic: Assessment of diastolic function

Speaker: Doctor T. Sakai (Kitakyushu, JP)

Event: EuroEcho-Imaging 2017

Congress Presentation

Add to my library

About the speaker

Doctor Takaaki Sakai

Koekizaiannhoin Miagino sptal, Kitakyushu (Japan)

0 follower

10 more presentations in this session

Panel of experts:

Access

Impact of new recommendations in the evaluation of left ventricular diastolic function by echocardiography

Speaker: Doctor L. Sanchis Ruiz (Barcelona, ES)

Resting echocardiography and biomarkers predict abnormal LV diastolic response and outcome in heart failure with preserved ejection fraction

Speaker: Professor M. Przewlocka-Kosmala (Wroclaw, PL)

Effect of age, sex, and cardiovascular risk factors on systolic and diastolic myocardial deformation Results from the population-based STAAB cohort study

Speaker: Doctor C. Morbach (Wuerzburg, DE)

Access

Abstract

Left ventricular vortex intensity and left ventricular diastolic function

Speaker: Doctor L. Takahashi (Tokyo, JP)

Access the full session

New insights in diastology

Speakers: Doctor T. Sakai, Doctor L. Sanchis Ruiz, Professor M. Przewlocka-Kosmala, Doctor C. Morbach, Doctor L. Takahashi

Access

About the event

EuroEcho-Imaging 2017

6 December - 9 December 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources